Carson Wealth (CWM LLC)
BNR

Carson Wealth (CWM LLC)’s Burning Rock Biotech BNR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 3976
2022
Q3 		$0 Buy
+1
New +$32 ﹤0.01% 3916

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Carson Wealth (CWM LLC)'s BNR Position: Q4 2022 in Review

Carson Wealth (CWM LLC) sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 1 share.

Carson Wealth (CWM LLC) first reported a position in BNR in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

  • Carson Wealth (CWM LLC) reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 1 Burning Rock Biotech share in Q4 2022.
  • Carson Wealth (CWM LLC) first reported a position in Burning Rock Biotech in Q3 2022 and held it in 1 quarter.
  • Carson Wealth (CWM LLC)'s Burning Rock Biotech position peaked at $0 in Q3 2022.
  • 42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2022, filed 1 Feb 2023.